Fundraising Fox

Synereca Pharmaceuticals

Oklahoma City, US · Delaware corporation

Healthtech

Founders & leadership

BW
Bennett W. LoveNamed on SEC filing
CI
Clayton I. DuncanNamed on SEC filing
SF
Scott F. SingletonNamed on SEC filing
MC
Mark CorriganNamed on SEC filing
RE
Richard E. GammansNamed on SEC filing
SM
Scott MeachamNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$600K disclosed across 1 round · 2017

▶$600KraisedAug 2017 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bennett W. LoveDirector
  • Clayton I. DuncanExecutive Officer, Director
  • Scott F. SingletonDirector
  • Mark CorriganDirector
  • Richard E. GammansExecutive Officer, Promoter
  • Scott MeachamDirector
Offering amount
$1.2M
Amount sold
$600K
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Synereca Pharmaceuticals nets $600Kventurecapitaljournal.com · Aug 2015Synereca Pharmaceuticals Raises $600K in Funding - FinSMEsfinsmes.com · Aug 2015Synereca Pharmaceuticals Announces Financing Led By Accele Venture Partners - BioSpacebiospace.com · Sep 2014UNC spinout raises $300K to build a better antibiotic - MedCity Newsmedcitynews.com · Feb 2011UNC-CH signs licensing deal with spin-out Synereca Pharmaceuticals | WRAL TechWirewraltechwire.com · Apr 2010

Frequently asked questions

How much funding has Synereca Pharmaceuticals raised?
Synereca Pharmaceuticals has disclosed $600K raised across 1 round.
Where is Synereca Pharmaceuticals headquartered?
Synereca Pharmaceuticals is headquartered in Oklahoma City, US.